- Title: Subtitle
- 1129 EWSR1::BEND2 Fusion Defines a Novel Salivary Gland Adenocarcinoma with a Predilection for the Pharynx: Description of an Emerging Entity and Validation of a Specific BEND2 Antibody
- Creators
- Dhuha Al-Sajee - Hamilton Health SciencesLisa Rooper - Johns Hopkins HospitalJustin Bishop - The University of Texas Southwestern Medical CenterDiana Bell - University of Pittsburgh Medical CenterSnjezana Dogan - Memorial Sloan Kettering Cancer CenterBin Xu - Memorial Sloan Kettering Cancer CenterElan Hahn - Sinai Health SystemAbbas Agaimy - Universitätsklinikum ErlangenAndrew Bellizzi - University of IowaIlan Weinreb - University Health Network
- Resource Type
- Abstract
- Publication Details
- Laboratory investigation, Vol.105(3 Supplement), 103364
- DOI
- 10.1016/j.labinv.2024.103364
- ISSN
- 0023-6837
- eISSN
- 1530-0307
- Publisher
- Elsevier Inc
- Language
- English
- Date published
- 03/2025
- Academic Unit
- Pathology
- Record Identifier
- 9984800203302771
Abstract
1129 EWSR1::BEND2 Fusion Defines a Novel Salivary Gland Adenocarcinoma with a Predilection for the Pharynx: Description of an Emerging Entity and Validation of a Specific BEND2 Antibody
Laboratory investigation, Vol.105(3 Supplement), 103364
03/2025
DOI: 10.1016/j.labinv.2024.103364
Details
Metrics
53 Record Views